Five-Year-Old Girl’s Life Depends On Drug That’s Being Discontinued

A five-year-old girl has been told the drug which has saved her life is being discontinued in just six months’ time. 

Marian McGlocklin has a fatal condition called Niemann-Pick Type C (NPC), also known as Childhood Alzheimer’s, and she depends on VTS-270/Adrabetadex.

But now the pharmaceutical company Mallinckrodt has revealed that the drug will no longer be distributed from October.

Seven-Year-Old Girl Is Single-Handedly Fundraising For Her Dad’s Life-Saving Cancer Treatment

The life-saving drug Marian uses is being discontinued. Credit: Sara McGlocklin

The five-year-old began taking the medicine when she was aged just 19 months. Before the drug, she couldn’t walk, wouldn’t gain weight, and was often very weak.

In a piece for Scary Mommy, her mum Sarah wrote: “We didn’t know if she would live to be two years old due to her aggressive infantile version of NPC.

“But then, it was like a miracle. After only five treatments with VTS-270, she started walking and thriving.

“It gives her life, and without it, she won’t have one.”

To stop it from being discontinued, Marian’s mum has launched a fundraiser on GoFundMe to raise $150,000.

The money will be used to hire a team of experts that can help stop the drug from being cancelled.

Sarah added: “She dreams of her future, wants to get married, be a doctor, and follow her big sister around everywhere she goes for the rest of her life.”

Featured Image Credit: Sara McGlocklin 

Do you have a story for us? If so, email us at [email protected]. All contact will be treated in confidence.

Written by Aimee Walker

Aimee is a senior content editor at IGV who specialises in finding the best original stories, trending topics and entertainment news. She graduated from Birmingham City University with a degree in Media and Communications.